Approval · Notice of Compliance 11971 · 2010
DRAXIMAGE MDP: Notice of Compliance 11971
Issued December 31, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11971
- Date
- December 31, 2010
- Company
- Jubilant Draximage Inc.Kirkland, Quebec, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Diagnostic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DRAXIMAGE MDP | Not yet assigned | — |
| DRAXIMAGE MDP-25 | Not yet assigned | — |
Medicinal ingredients
- MEDRONIC ACID 10 MG per VIAL
- MEDRONIC ACID 25 MG per VIAL